Letter to the Editor: Possible Drug–Drug Interactions Between Cannabinoids and Candidate COVID-19 Drugs

Abstract

Get full access to this article

View all access options for this article.

References

Foster

, Abramovici

, Harris

. Cannabis and cannabinoids: Kinetics and interaction. Am J Med. 2019; 132:1266–1270.

Epidiolex Package

Insert

. In: GB

Inc.

, ed. FDA approved 2018. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210365lbl.pdf Accessed March 24, 2020.

Marinol Package

Insert

. In: AbbieVie, Inc., ed. FDA approved 1985, revised 2017. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018651s029lbl.pdf Accessed March 24, 2020.

McCreary

, Pogue

. COVID-19 treatment: A review of early and emerging options. Open Forum Infect Dis. 2020; 7:ofaa105.

Nichols

, Kaplan

BLF

. Immune responses modulated by cannabidiol. Cannabis Cannabinoid Res. 2020; 5:12–31.

Kusher

, Dawson

, Taylor

, et al. Effect of the psychoactive metabolites of marijuana, delta 9-tetrahydrocannabinol (THC), on the synthesis of tumor necrosis factor by human large granular lymphocytes. Cell Immunol. 1994; 154:99–108.

Vuolo

, Petronilho

, Sonai

, et al. Evaluation of serum cytokines levels and the role of cannabidiol treatment in animal model of asthma. Mediators Inflamm. 2015; 2015:538670.

Muthumalage

, Rahman

. Cannabidiol differentially regulates basal and LPS-induced inflammatory responses in macrophages, lung epithelial cells, and fibroblasts. Toxicol Appl Pharmacol. 2019; 382:114713.